UNSPSC 51143202: Nicotine

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6M3C89ZY6R, chemically known as xl all insecti-cide, emo-nib but generally known as nicotine, which bears US NIH Compound Identifier 942. European Medicines Agency schedules Nicotine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14645MIG. World Health Organization schedules nicotine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations schedule nicotine under HS 29399990 and SITC 54149. As of Q4 2014, NICOTINE remains the US FDA Preferred Term for this commodity. Nicotine bears US NLM identifiers UMLS ID C0028040 and NCI Concept Code C691. SMILES: CN1CCCC1C2=CN=CC=C2.

UNSPSC 51143202 Nicotine is a Commodity code that shows minimal alignment with actual state and local procurement activity. The recent opportunities tagged to this code do not reflect nicotine products; instead, they document solicitations for naloxone (an opioid antagonist) and prescription pharmacy benefit management services—neither of which fall within the nicotine commodity scope. Issuing bodies posting under this code span county health departments and state health commissions, but the mismatch between the code's nominal scope and the work actually being bought suggests this code may be misapplied in state and local procurement systems or sees little authentic activity in the nicotine category itself.

The only concrete recent opportunity is Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, response deadline July 26, 2023), which solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building. The second posting—Texas Health and Human Services Commission RFI HHS0017013 (posted April 3, 2026)—requests vendor information on direct-to-manufacturer prescription fulfillment capabilities for a Therapeutic Pharmacy Initiative, representing strategic market research rather than a procurement of nicotine products. Given the absence of recent solicitations actually buying nicotine or nicotine-related products at the state and local level, this code appears inactive or mistagged in current procurement systems.